, /PRNewswire/ -- , a world leader in the field of diagnostics, is pleased to announce the incorporation of the company's GENE-UP CAMPYLOBACTER assay into the methodology used by the USDA-FSIS Field Service Laboratories. "We are thrilled to be awarded this contract by the USDA-FSIS. With the inclusion of GENE-UP CAMPYLOBACTER, bioMérieux now has the most FSIS methods of choice for microbiology than any other diagnostics provider," says Vice President, Americas, Industrial Applications, at bioMérieux.
"This is a testament to our continued dedication to providing innovation within the animal protein sector and the food industry at large, reinforcing GENE-UP as the full solution for all molecular testing needs in one place." The GENE-UP CAMPYLOBACTER assay is the latest of bioMérieux's molecular diagnostic solutions to be recognized by food safety regulatory bodies in . Earlier this year, bioMérieux announced of food-borne pathogens with the Food and Drug Administration, and in 2022, the USDA named bioMérieux's with both GENE-UP QUANT Salmonella and TEMPO solutions currently included in the USDA Microbiology Laboratory Guidebook (MLG).
"Our Augmented Diagnostics approach helps food industry leaders go beyond the test results and harness data, genomics, and diagnostic insights to solve the toughest problems," says , Sr. Director, Sales and Marketing, Industrial Applications, at bioMérieux. "The recognition of GENE-UP CAMPYLOBACTER as the method of choice of the USDA i.
